2017 American Transplant Congress
Restrictive Approach to Simultaneous Liver Kidney Transplantation.
Surgery, University of Maryland School of Medicine, Baltimore
Purpose: MELD based allocation and “Share 35” policy implementation has resulted in an overall increased incidence of renal failure at the time of liver transplantation,…2017 American Transplant Congress
Liver Retransplantation: The Largest Post MELD Single Center Experience.
Surgery, University of California Los Angeles, Los Angeles, CA
OBJECTIVE: Analyze post MELD liver retransplantation (Re-OLT) and identify recipient and donor preoperative risk factors associated with poor patient outcomes.BACKGROUND: Re-OLT is a high risk…2017 American Transplant Congress
Phenotypic and Functional Assessment of T Cell Alloimmunity After Liver Transplantation.
In addition to its metabolic functions, the liver is also an immunologically active organ. Liver transplant recipients are often maintained on less immunosuppression when compared…2017 American Transplant Congress
Infectious Complications Following Hepatectomy for Pediatric Hepatoblastoma.
Pediatric Surgery, Baylor College of Medicine, Houston, TX
Purpose: To examine if patients with hepatoblastoma (HB) treated with both immunosuppression and chemotherapy have different rates of infection post-operatively than those treated with chemotherapy…2017 American Transplant Congress
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.
Background: Post transplant course of circulating de novo donor specific antibodies (DSA) remains unknown after liver transplantation (LT).Methods: In a prospective study, sera from 92…2017 American Transplant Congress
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.
Background: Enhanced recovery after surgery protocol has proven its efficacy in many surgery fields in controlling pain and promoting early recovery . The implication of…2017 American Transplant Congress
AAV8 Delivery of TIMP-1 Prevents Hepatocyte Apoptosis After Liver Ischemia/Reperfusion Injury.
Dumont-UCLA Transplant Center, Los Angeles
Matrix metalloproteinase-9 (MMP-9) is a key mediator of leukocyte migration across vascular barriers in hepatic ischemia/reperfusion injury (IRI). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the…2017 American Transplant Congress
Disparity in Transplant Referral Patterns Based on Physician Dependent Variables.
Loyola University Medical Center, Maywood, Il
Introduction: Distance from a liver transplant (LT) center does not affect outcomes; however, rural areas have lower rates of listing and receiving solid organ transplants.…2017 American Transplant Congress
This is Why We Can't Have Nice Things- Real World Experience with Everolimus in Livers.
Purpose: To determine if discontinuation rates of everolimus (RAD) in clinical practice is higher than the 30% demonstrated in trials.Methods: This was a retrospective cohort…2017 American Transplant Congress
Hepatic Ischemia Reperfusion Injury After Liver Transplantation Is Associated with Acute Kidney Injury.
Background: The impact of liver allograft ischemia/reperfusion injury (IRI) on native renal function remains to be characterized. We hypothesized that severity of IRI correlates with…
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 50
- Next Page »